These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 1722335
1. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. Sharma SD, Nag B, Su XM, Green D, Spack E, Clark BR, Sriram S. Proc Natl Acad Sci U S A; 1991 Dec 15; 88(24):11465-9. PubMed ID: 1722335 [Abstract] [Full Text] [Related]
2. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. Sakai K, Zamvil SS, Mitchell DJ, Hodgkinson S, Rothbard JB, Steinman L. Proc Natl Acad Sci U S A; 1989 Dec 15; 86(23):9470-4. PubMed ID: 2480602 [Abstract] [Full Text] [Related]
7. Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis. Fugger L, Liang J, Gautam A, Rothbard JB, McDevitt HO. Mol Med; 1996 Mar 20; 2(2):181-8. PubMed ID: 8726461 [Abstract] [Full Text] [Related]
8. Parental MHC molecule haplotype expression in (SJL/J x SWR)F1 mice with acute experimental allergic encephalomyelitis induced with two different synthetic peptides of myelin proteolipid protein. Sobel RA, Tuohy VK, Lees MB. J Immunol; 1991 Jan 15; 146(2):543-9. PubMed ID: 1702806 [Abstract] [Full Text] [Related]
9. Subtle effects on myelin basic protein-specific T cell responses can lead to a major reduction in disease susceptibility in experimental allergic encephalomyelitis. Vowles C, Chan VS, Bodmer HC. J Immunol; 2000 Jul 01; 165(1):75-82. PubMed ID: 10861037 [Abstract] [Full Text] [Related]
10. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production. Karin N, Mitchell DJ, Brocke S, Ling N, Steinman L. J Exp Med; 1994 Dec 01; 180(6):2227-37. PubMed ID: 7525850 [Abstract] [Full Text] [Related]
11. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex. Aharoni R, Teitelbaum D, Arnon R, Puri J. Nature; 1991 May 09; 351(6322):147-50. PubMed ID: 1709449 [Abstract] [Full Text] [Related]
12. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Sakai K, Sinha AA, Mitchell DJ, Zamvil SS, Rothbard JB, McDevitt HO, Steinman L. Proc Natl Acad Sci U S A; 1988 Nov 09; 85(22):8608-12. PubMed ID: 2460872 [Abstract] [Full Text] [Related]
13. Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition. Zamvil SS, Nelson PA, Mitchell DJ, Knobler RL, Fritz RB, Steinman L. J Exp Med; 1985 Dec 01; 162(6):2107-24. PubMed ID: 2415664 [Abstract] [Full Text] [Related]
14. T cell recognition in experimental autoimmune encephalomyelitis: prospects for immune intervention with synthetic peptides. Wraith DC, Smilek DE, Mitchell DJ, Steinman L, McDevitt HO. Int Rev Immunol; 1990 Dec 01; 6(1):37-47. PubMed ID: 1715375 [Abstract] [Full Text] [Related]
15. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. Kennedy MK, Tan LJ, Dal Canto MC, Tuohy VK, Lu ZJ, Trotter JL, Miller SD. J Immunol; 1990 Feb 01; 144(3):909-15. PubMed ID: 1688591 [Abstract] [Full Text] [Related]
16. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H. J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788 [Abstract] [Full Text] [Related]
17. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II. Abromson-Leeman S, Alexander J, Bronson R, Carroll J, Southwood S, Dorf M. J Immunol; 1995 Jan 01; 154(1):388-98. PubMed ID: 7527816 [Abstract] [Full Text] [Related]
18. Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes. Sriram S, Steinman L. J Exp Med; 1983 Oct 01; 158(4):1362-7. PubMed ID: 6194246 [Abstract] [Full Text] [Related]
19. Treatment of chronic relapsing experimental allergic encephalomyelitis with the intravenous administration of splenocytes coupled to encephalitogenic peptide 91-103 of myelin basic protein. Su XM, Sriram S. J Neuroimmunol; 1991 Nov 01; 34(2-3):181-90. PubMed ID: 1717504 [Abstract] [Full Text] [Related]
20. T cell recognition of distinct peptide:I-Au conformers in murine experimental autoimmune encephalomyelitis. Huang JC, Han M, Minguela A, Pastor S, Qadri A, Ward ES. J Immunol; 2003 Sep 01; 171(5):2467-77. PubMed ID: 12928395 [Abstract] [Full Text] [Related] Page: [Next] [New Search]